Beijing Biostar Pharmaceuticals Co., Ltd. (HKG:2563)
Hong Kong · Delayed Price · Currency is HKD 3.800
-0.050 (-1.30%)
At close: Mar 27, 2026
HKG:2563 Market Cap
HKG:2563 has a market cap or net worth of 1.39 billion as of March 27, 2026. Its market cap has decreased by -86.99% in one year.
Market Cap
1.39B
Enterprise Value
813.23M
Revenue
58.66M
Ranking
n/a
PE Ratio
n/a
Stock Price
3.80
Market Cap Chart
Since October 31, 2024, HKG:2563's market cap has decreased from 7.58B to 1.39B, a decrease of -81.73%. That is a compound annual growth rate of -70.24%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 27, 2026 | 1.39B | -22.29% |
| Dec 31, 2025 | 1.78B | -75.18% |
| Dec 31, 2024 | 7.18B | -5.29% |
| Oct 31, 2024 | 7.58B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Hangzhou Jiuyuan Genetic Biopharmaceutical | 1.91B |
| ImmuneOnco Biopharmaceuticals (Shanghai) | 1.88B |
| HighTide Therapeutics | 1.77B |
| Cutia Therapeutics | 1.74B |
| Zhaoke Ophthalmology | 1.64B |
| Immunotech Biopharm | 1.62B |
| CANbridge Pharmaceuticals | 1.55B |
| Kintor Pharmaceutical | 1.46B |